GMWYX | RBDTX | GMWYX / RBDTX | |
Total Expense Ratio | 0.45 | 1.40 | 32% |
Annual Report Gross Expense Ratio | 0.51 | 1.40 | 36% |
Fund Existence | 8 years | 18 years | - |
Gain YTD | 6.490 | 7.666 | 85% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2B | 32.6B | 6% |
Annual Yield % from dividends | 3.31 | 1.67 | 198% |
Returns for 1 year | 4.64 | 7.04 | 66% |
Returns for 3 years | 16.72 | 21.04 | 79% |
Returns for 5 years | 16.24 | 17.43 | 93% |
Returns for 10 years | N/A | 35.39 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EWA | 26.45 | 0.17 | +0.65% |
iShares MSCI Australia ETF | |||
IBIE | 26.14 | N/A | N/A |
iShares iBonds Oct 2028 Term Tips ETF | |||
OGSP | 10.05 | N/A | N/A |
Obra High Grade Structured Products ETF | |||
ICLO | 25.61 | -0.04 | -0.16% |
Invesco AAA CLO Floating Rate Note ETF | |||
HELX | 27.13 | -0.37 | -1.34% |
Franklin Genomic Advancements ETF |